NCT07068529View on ClinicalTrials.gov

Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2030

Conditions

Colorectal Cancer

Trial Locations (1)

200025

RECRUITING

Ruijin hospital Shanghai Jiaotong University, School of Medicine, Shanghai

All Listed Sponsors

lead

Shanghai Minimally Invasive Surgery Center

OTHER